Artificial intelligence has moved well beyond the experimental phase in the life sciences industry, and is now embedded across the value chain from early-stage drug discovery through manufacturing and commercial operations, and the pace of adoption is only accelerating. Understanding where AI delivers real value, and where challenges remain, is essential for informed strategic planning….
By: Foley Hoag LLP
By: Foley Hoag LLP
